Question · Q4 2025
Aziza Gazieva, representing Fermium Research, asked for insights into Celanese's expectations for Chinese acetyls pricing throughout 2026. She also inquired whether the company had quantified the earnings impact of the second-quarter POM turnaround.
Answer
Scott Richardson, President and CEO of Celanese, stated that Chinese acetyls pricing is expected to remain stable within recent ranges, with no significant uplifts anticipated, and noted stable pricing despite low demand during Chinese New Year. Regarding the Q2 POM turnaround, Mr. Richardson indicated an earnings impact similar to the $30 million Q1 inventory benefit, clarifying that these major turnarounds occur every five years due to enhanced reliability and are confined to Q2.
Ask follow-up questions
Fintool can predict
CE's earnings beat/miss a week before the call
